Neuroregenerative and neuroprotective properties of dopamine D3 receptor agonists in human dopaminergic neurons derived from iPSC

被引：0
|
作者：
Cavalleri, L. [1 ]
Millan, M. J. [2 ]
Collo, G. [1 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy
[2] Inst Rech Servier, Pole Innovat Neuropsychiat, Croissy Sur Seine, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
D O I：
10.1016/j.euroneuro.2019.09.317
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.288
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [1] Neuroprotective effects of D3 dopamine receptor agonists
    Carvey, PM
    McGuire, SO
    Ling, ZD
    PARKINSONISM & RELATED DISORDERS, 2001, 7 (03) : 213 - 223
  • [2] Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons
    Federica Bono
    Paola Savoia
    Adele Guglielmi
    Massimo Gennarelli
    Giovanna Piovani
    Sandra Sigala
    Damiana Leo
    Stefano Espinoza
    Raul R. Gainetdinov
    Paola Devoto
    PierFranco Spano
    Cristina Missale
    Chiara Fiorentini
    Molecular Neurobiology, 2018, 55 : 1054 - 1067
  • [3] Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons
    Bono, Federica
    Savoia, Paola
    Guglielmi, Adele
    Gennarelli, Massimo
    Piovani, Giovanna
    Sigala, Sandra
    Leo, Damiana
    Espinoza, Stefano
    Gainetdinov, Raul R.
    Devoto, Paola
    Spano, PierFranco
    Missale, Cristina
    Fiorentini, Chiara
    MOLECULAR NEUROBIOLOGY, 2018, 55 (02) : 1054 - 1067
  • [4] Ketamine and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via D3 receptor and mTOR pathway
    Cavalleri, L.
    Pich, E. Merlo
    Chiamulera, C.
    Millan, M. J.
    Collo, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S644 - S644
  • [5] 17β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons
    Sbrini, Giulia
    Mutti, Veronica
    Bono, Federica
    Tomasoni, Zaira
    Fadel, Dounia
    Missale, Cristina
    Fiorentini, Chiara
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 976
  • [6] Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons
    Du, F
    Li, R
    Huang, YG
    Li, XP
    Le, WD
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (10) : 2422 - 2430
  • [7] Dopamine D3 receptor agonists as pharmacological tools
    Kassel, S.
    Schwed, J. S.
    Stark, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (09) : 1480 - 1499
  • [8] Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons
    Collo, G.
    Bono, F.
    Cavalleri, L.
    Spano, P. F.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2014, 53 : S30 - S30
  • [9] Ocular action of dopamine D3 receptor agonists.
    Chu, TC
    Luo, YQ
    Potter, DE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S742 - S742
  • [10] Identification and characterization of novel properties of the human D3 dopamine receptor
    Kuzhikandathil, EV
    Westrich, L
    Bakhos, S
    Pasuit, J
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 26 (01) : 144 - 155
12345